The GLP is committed to full transparency. Download and review our 2019 Annual Report

Viewpoint: AI may boost our diagnostic abilities, but it’s not ready to replace human doctors

4-23-2019 dsc
Image: Emily Graf
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

I read a recent article in Nature Medicine about new inroads in deploying artificial intelligence (AI) in pediatrics. In the article, researchers report their success in using AI to mine electronic health records as a diagnostic tool. As the authors point out, this is not just a matter of making clinicians’ lives easier: missed diagnoses and misdiagnoses occur with disturbing frequency, leading to increased morbidity and mortality and higher costs.

However, I must sound a note of caution. While AI may be helpful in diagnosis, unless a day comes when machines can fully replicate human thought and emotions, we should be wary of allowing AI to move beyond diagnosis and actually make medical management decisions for us.

Related article:  What makes human brain cells so powerful?

Viewing this from the perspective of pediatric palliative care, though incorporating AI seems very tempting, I worry that radical integration could be shortsighted. The key to navigating complex decisions with families involves careful examination of hopes, fears, values and goals.

Should AI be used to augment medical decision making? Absolutely, and we’re just beginning to explore the ways in which that might manifest itself. But replacing human beings is a separate issue altogether.

Read full, original post: Where AI in Medicine Falls Short

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend